AtriCure, Inc. provided revenue guidance for the year 2022. Management projects 2022 revenue of approximately $315 million to $330 million, reflecting growth of approximately 15% to 20% over full year 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.54 USD | +1.26% | +0.36% | -36.85% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.85% | 1.08B | |
-7.16% | 177B | |
-4.86% | 65.54B | |
-4.28% | 47.09B | |
+10.32% | 43.43B | |
+8.14% | 41.77B | |
+15.76% | 29.55B | |
+15.53% | 24.83B | |
-5.88% | 23.97B | |
-5.38% | 23.54B |
- Stock Market
- Equities
- ATRC Stock
- News AtriCure, Inc.
- AtriCure, Inc. Provides Revenue Guidance for the Year 2022